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Abstract
Background A significant proportion of gallbladder polyps are non-neoplastic, for which resection is not necessary. However, 
international guidelines advocate cholecystectomy for all polyps ≥ 1 cm. This study assessed a national cohort of histopatho-
logically proven gallbladder polyps to distinguish neoplastic from non-neoplastic polyps.
Methods PALGA, the nationwide network and registry of histo- and cytopathology, was searched to identify all histopatho-
logically proven gallbladder polyps between 2003 and 2013. All polyps and (focal) wall thickenings > 5 mm were included, 
and classified as neoplastic or non-neoplastic. Polyp subtype, size, distribution, presentation as wall thickening or protrud-
ing polyp, and presence of gallstones were assessed for neoplastic and non-neoplastic polyps. A decision tree to distinguish 
neoplastic and non-neoplastic polyps was made and diagnostic accuracy of 1 cm surgical threshold was calculated.
Results A total of 2085 out of 220,612 cholecystectomies contained a polyp (0.9%). Of these polyps, 56.4% were neoplastic 
(40.1% premalignant, 59.9% malignant) and 43.6% non-neoplastic (41.5% cholesterol polyp, 37.0% adenomyomatosis, 21.5% 
other). Polyp size, distribution, and presence of gallstones were reported in 1059, 1739 and 1143 pathology reports, respec-
tively. Neoplastic polyps differed from non-neoplastic polyps in size (18.1 mm vs 7.5 mm, p < 0.001), singularity (88.2% 
vs 68.2%, p < 0.001), wall thickening (29.1% vs 15.6%, p < 0.001), and presence of gallstones (50.1% vs 40.4%, p = 0.001). 
However, adenomyomatosis presented with similar characteristics as neoplastic polyps. Fifty percent of polyps were ≥ 1 cm 
surgical threshold (optimal surgical threshold based on ROC-curve); sensitivity for indicating neoplastic polyps was 68.1%, 
specificity was 70.2%, and positive and negative predictive values were 72.9% and 65.1%.
Conclusions The prevalence of gallbladder polyps on cholecystectomy is low and many of the polyps are non-neoplastic. 
Clinicopathological characteristics differ between neoplastic and non-neoplastic polyps in general, but these cannot properly 
indicate neoplasia. The 1 cm surgical threshold has moderate diagnostic accuracy and is insufficient to indicate surgery for 
neoplastic gallbladder polyps.
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Annually, 800,000 cholecystectomies are performed in 
the United States and 23,000 in the Netherlands [1, 2]. 
Gallbladder polyps, defined as elevated (mucosal) lesions 
projecting into the lumen of the gallbladder [3], are found in 
0.6–4% of cholecystectomies [4–6]. Gallbladder polyps can 
be categorized as neoplastic or non-neoplastic polyps based 
on histopathological evaluation. Neoplastic polyps include 
all cancerous lesions (most commonly adenocarcinoma) and 
precursors of cancer (all types of adenomas) [3, 7–9]. Non-
neoplastic polyps consist of an aggregation of tumor-like 
lesions without malignant potential, including cholesterol 
polyps, inflammatory polyps, and adenomyomatosis [3, 7, 
8]. An accurate estimate of the prevalence of neoplastic and 
non-neoplastic polyp types is lacking.
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The presence of gallbladder polyps causes a clinical prob-
lem, since surgery is only absolutely indicated for neoplastic 
polyps, including adenomas in view of their assumed malig-
nant potential [10–13]. While international guidelines have 
various recommendations for the indication of cholecystec-
tomy in general [14], it is of interest that American [15] and 
other western countries [16–18] advocate cholecystectomy 
for polyps ≥ 1 cm. For polyps < 1 cm, cholecystectomy is 
only suggested in patients with additional risk factors for 
malignancy (e.g., older age or primary sclerosing cholangitis 
(PSC)) or in case of biliary symptoms without alternative 
causes [16, 17].
The surgical threshold size is based on older retrospective 
studies that demonstrated that polyps with a diameter ≥ 1 cm 
are more likely to be neoplastic [7, 19–22]. However, the 
accuracy of size as a determinant of malignant potential 
is limited [22–25]. Identification of clinicopathological or 
clinical characteristics that distinguishes gallbladder polyps 
on basis of the malignant potential is desirable. Discrimina-
tive characteristics could improve pre-operative work-up and 
optimize indication for cholecystectomy, to avoid unneces-
sary surgery related morbidity and costs.
In order to achieve this goal, we collected clinicopatho-
logical data over a 10-year period from all gallbladder pol-
yps that were available from the Dutch nation-wide pathol-
ogy registry. Our aim was to define characteristics that 
enable differentiation between neoplastic and non-neoplastic 
polyps.
Methods
Patient identification
We searched PALGA, the Dutch nationwide network and 
registry of histopathology and cytopathology, to identify all 
patients with histopathologically proven gallbladder polyps 
between January 2003 and December 2013 in the Nether-
lands. PALGA contains pathology reports of all pathol-
ogy laboratories of academic and non-academic hospitals 
in the Netherlands, and has complete coverage of reports 
since 1991 [26]. A search was performed with the search 
term “gallbladder” combined with “polyp” or “adenoma” 
or “adenomatous polyp” or “hyperplastic polyp” or “dys-
plasia” or “cholesterolosis” or “all benign neoplasms” or 
“all primary malignancies (incl. cis)”, or the individual 
search term “cholesterol polyp”. The search was restricted 
to histological samples of patients ≥ 18 years of age. Patients 
were further included or excluded after critical review of the 
individual pathology reports. Biopsies, cholecystectomies 
performed as part of primary non-gallbladder surgery (e.g., 
pancreatectomy or hepatectomy), and duplicates (e.g., due 
to second opinions at another pathology lab) were excluded. 
All patients with a polyp or (focal) wall thickening > 5 mm 
in the gallbladder, were included.
Datacollection and histopathologicl assessment
The following variables were, if reported, extracted from 
the individual pathology reports: polyp subtype, polyp 
size, number of polyp(s), presentation as protruding polyp 
or wall thickening, and presence of gallstones. All polyps 
were subsequently categorized as neoplastic ((cyst)adenoma, 
adenocarcinoma, or other malignancies) or non-neoplastic 
(all other polyp subtypes). If both neoplastic and non-neo-
plastic polyps were present in one gallbladder, overall polyp 
type was categorized as neoplastic. If multiple histopatho-
logical subtypes of neoplastic polyps were present, overall 
subtype was classified according the most severe neoplas-
tic histopathological subtype. If multiple histopathological 
subtypes of non-neoplastic polyps were present, overall 
subtype was classified according the most relevant (in pres-
ence or amount) non-neoplastic histopathological subtype. 
Polyp size was classified as the largest measurement from 
the pathology report, and in case of multiple polyps as the 
size of the largest polyp present.
Outcomes and analyses
Prevalence of gallbladder polyps was defined as the pro-
portion of patients presenting with gallbladder polyps per 
100,000 primary cholecystectomies between 2003 and 2013. 
Clinicopathological characteristics (size in mm, number of 
polyps, presentation as wall thickening, and presence of gall-
stones) were reported for neoplastic and non-neoplastic pol-
yps in general, and for main neoplastic and non-neoplastic 
subtypes. Number or patients for whom these characteristics 
were available will be reported. Chi square and independent 
student T test statistics were performed to compare groups. 
A p value < 0.05 was considered statistically significant. Pro-
portions of the different subgroups above and below surgi-
cal threshold of 1 cm were reported separately. Sensitivity, 
specificity, and predictive values of the 1 cm threshold were 
calculated, and a receiver operating characteristic (ROC) 
curve was used to determine the optimal size threshold for 
differentiating neoplastic and non-neoplastic polyps. The 
surgical threshold data and clinicopathological characteris-
tics were assessed in a simple decision tree to establish com-
bined discernment for neoplastic and non-neoplastic polyps. 
All statistical analyses were performed using SPSS Statistics 
22.0 (IBM, Amsterdam, The Netherlands). All authors had 
access to the study data and have reviewed and approved the 
final manuscript.
1566 Surgical Endoscopy (2019) 33:1564–1571
1 3
Results
Epidemiology
We identified a total of 220,612 primary cholecystectomies 
between 2003 and 2013. The search strategy resulted in 
4008 evaluated patients, and subsequent critical review of 
the pathology reports identified 2085 (0.9%) patients with 
a gallbladder polyp (Fig. 1). The prevalence of gallbladder 
polyps was 945 per 100,000 cholecystectomies.
Eleven hundred seventy-five polyps (56.4%) were neo-
plastic and 910 (43.6%) were non-neoplastic. Neoplastic pol-
yps consisted of 471 (40.1%) premalignant and 704 (59.9%) 
malignant polyps. The main non-neoplastic subtypes were 
cholesterol polyps (n = 378, 41.5%) and adenomyomatoses 
(n = 337, 37.0%). The histopathological subtypes of neoplas-
tic polyps and non-neoplastic polyps are illustrated in Fig. 2.
220,612 primary 
cholecystectomies
4532 patients identified 
with PALGA search
4008 patients evaluated
2085 patients
with gallbladder polyp
524 patients excluded:
• 186 duplicates
• 13 biopsies
• 325 primary non-gallbladder surgery
Fig. 1  Flowchart patient identification
Fig. 2  Histopathological subtypes of neoplastic and non-neoplastic 
polyps. *Consists of: squamous cell carcinoma (n = 13), lymphoma 
(n = 10), metastasis (n = 9), carcinoïd (n = 5), other neuroendocrine 
tumor (n = 5), sarcoma (n = 5), papillary carcinoma (n = 4), undiffer-
entiated carcinoma (n = 4), granular cell myoblastoma (n = 2), mela-
noma (n = 1), colloid carcinoma (n = 1), spindle and giant cell carci-
noma (n = 1), small cell carcinoma (n = 1). ^Consists of: hemangioma 
(n = 4), lipoma (n = 3), lymphangioma (n = 3), fibroma (n = 3), follicu-
lar cholecystitis (n = 2), and non-specified polyp (n = 66)
Table 1  Clinicopathological 
characteristics of neoplastic and 
non-neoplastic polyps
*Significantly different from nonneoplastic polyps (all p < 0.001); ^significantly different from malignant 
polyps (all p < 0.001); +significantly different from other nonneoplastic polyps (all p < 0.003)
Size in mm 
(n = 1059), µ 
(SD)#1
Single polyp 
(n = 1739), n/n 
(%)
Wall thickening 
(n = 2085), n/n (%)
Gallstones 
(n = 1143), n/n 
(%)
Neoplastic 18.1 (17.9)* 847/960 (88.2)* 342/1175 (29.1)* 318/635 (50.1)*
Adenoma (incl. dysplasia) 10.9 (8.8)^ 266/350 (76.0)^ 75/471 (15.9)^ 144/294 (49.0)
Malignant polyp 23.1 (20.6) 581/610 (95.2) 267/704 (37.9) 174/341 (51.0)
Non-neoplastic 7.5 (5.9) 531/779 (68.2) 142/910 (15.6) 205/508 (40.4)
Cholesterol polyp 5.2 (5.1)+ 138/327 (42.2)+ 3/378 (0.8)+ 70/221 (31.7)+
Adenomyomatosis 10.8 (5.7)+ 280/291 (96.2)+ 111/337 (32.9)+ 92/187 (49.2)
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Clinicopathological characteristics
Polyp size, number of polyps, and presence of gallstones 
were respectively reported in 1059, 1739 and 1143 pathol-
ogy reports. Information on presentation as protruding polyp 
or wall thickening was available for all polyps. Neoplas-
tic polyps were larger compared to non-neoplastic polyps 
(18.1 mm vs 7.5 mm, p < 0.001) and more often were pre-
sent as a single polyps (88.2% vs 68.2%, p < 0.001), as wall 
thickening rather than a lumen protruding polyp (29.1% vs 
15.6%, p < 0.001), and in the presence of gallstones (50.1% 
vs 40.4%, p = 0.001). There were a number of characteristics 
that were present more often in malignant neoplastic polyps 
compared to premalignant neoplastic polyps such as a larger 
size (23.1 mm vs 10.9 mm, p < 0.001), presentation as a 
single polyp (95.2% vs 76.0%, p < 0.001), and presentation 
as wall thickening (37.9% vs 15.9%, p < 0.001) (Table 1).
Clinicopathological characteristics also differed within 
main non-neoplastic subtypes, as illustrated in Table 1. 
Interestingly, adenomyomatosis differed from other non-
neoplastic polyps on all assessed characteristics, but pre-
sented with characteristics similar to neoplastic polyps in 
general (presentation as wall thickening and in the presence 
of gallstones), premalignant polyps (size), or malignant pol-
yps (number of polyps).
Fig. 3  Surgical threshold. Gallbladder polyps and subgroups above 
and below surgical threshold of 1 cm. Neoplastic polyps significantly 
differed from non-neoplastic polyps (p < 0.001). Pre-malignant pol-
yps significantly differed from malignant polyps (p < 0.001). Choles-
terol polyps significantly differed from other non-neoplastic polyps 
(p < 0.001). Adenomyomatosis significantly differed from other non-
neoplastic polyps (p < 0.001)
Fig. 4  ROC-curve polyp size. ROC-curve of polyp size compared 
for neoplastic polyp type. Area under the curve: 0.75 (95% CI 0.72–
0.78). Optimal diagnostic cut-off size is 1 cm with sensitivity of 0.68 
and specificity of 0.70 (p < 0.001). Sensitivities and specificities for 
all cut-off values are provided as supplementary table
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Surgical threshold
Fifty percent (n = 535) of the polyps, for which size was 
available, met the ≥ 1  cm surgical threshold; 67.9% of 
neoplastic polyps and 29.9% of non-neoplastic polyps 
(p < 0.001) (Fig. 3). The ROC-curve (Fig. 4) showed that 
1 cm is the most optimal size threshold for differentiating 
neoplastic and non-neoplastic polyps. Sensitivity of the sur-
gical threshold for indicating neoplastic polyps was 68.1%, 
specificity was 70.2%, and positive and negative predictive 
values were 72.9% and 65.1%. The 1 cm surgical threshold 
would have identified 47.2% of pre-malignant and 82.1% 
of malignant polyps, and 11.9% of cholesterol polyps and 
59.4% of adenomyomatoses.
Fig. 5  Surgical threshold and 
clinicopathological character-
istic decision tree. Presented as 
characteristic, n (%). Size avail-
able for n = 1059, number of 
polyps and wall thickening for 
n = 985, presence of gallstones 
and polyp type n = 574. NP 
neoplastic polyp, NNP nonneo-
plastic polyp
Polyp
< 1 cm, 524 (49.5)
Single, 296 (63.2)
Wall thickening, 81 (27.4)
Gallstones, 30 (68.2)
NP, 18 (60)
NNP, 12 (40)
No gallstones, 14 (31.8)
NP, 7 (50)
NNP, 7 (50)
Protruding polyp, 215  (72.6)
Gallstones, 46 (36.5)
NP, 20 (43.5)
NNP, 26 (56.5)
No gallstones, 80 (63.5)
NP, 21 (26.2)
NNP, 59 (73.8)
Mulple, 172 (36.8)
Wall thickening, 2 (1.2)
Gallstones, 0 (0)
No gallstones, 1 (100) NP, 1 (100)
Protruding polyp, 170 (98.8)
Gallstones, 35 (34.7)
NP, 6 (17.1)
NNP, 29 (82.9)
No gallstones, 66 (65.3)
NP, 14 (21.2)
NNP, 52 (78.8)
≥ 1 cm, 535 (50.5)
Single, 471 (91.1)
Wall thickening, 110 (23.4)
Gallstones, 36 (56.3)
NP, 30 (83.3)
NNP, 6 (16.7)
No gallstones, 28 (43.8)
NP, 20 (71.8)
NNP, 8 (28.6)
Protruding polyp, 361 (76.6)
Gallstones, 97 (45.3)
NP, 70 (72.2)
NNP, 27 (27.8)
No, gallstones 117 (54.7)
NP, 78 (66.7)
NNP, 39 (33.3)
Mulple, 46 (8.9)
Wall thickening, 1 (2.2) NP, 1 (100)
Protruding polyp, 45 (97.8)
Gallstones, 10 (41.7)
NP, 8 (80)
NNP, 2 (20)
No gallstones, 14 (58.3)
NP, 9 (64,3)
NNP, 5 (35.7)
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Prediction of neoplastic and non‑neoplastic polyp 
type
We established the decision tree in Fig. 5 using the surgi-
cal threshold data and clinicopathological characteristics 
of neoplastic and non-neoplastic polyps. The model starts 
with polyp size under or above 1 cm, followed by branches 
indicating number of polyps, presentation, and presence of 
gallstones. This decision tree results in the prediction of 
neoplastic or non-neoplastic polyp type for each of the 16 
possible combinations of clinicopathological characteris-
tics. The highest chances of neoplasia are seen for single 
polyps ≥ 1 cm presenting as wall thickening in the pres-
ence of gallstones, and for multiple polyps presenting as 
wall thickening irrespective of size and gallstones (83.3% 
and 100% respectively). Multiple protruding polyps < 1 cm 
in the presence of gallstones have the highest chance of 
being non-neoplastic polyps (82.9%). The lowest predictive 
combination is for single polyps < 1 cm presenting as wall 
thickening without gallstones (50% chance of neoplastic c.q. 
non-neoplastic polyp).
Discussion
This large nation-wide cohort study provides epidemio-
logical and clinicopathological data of gallbladder polyps 
over a 10-year period in the Netherlands. The present study 
illustrates that neoplastic gallbladder polyps generally dif-
fer from non-neoplastic gallbladder polyps in size, num-
ber, presentation, and concomitant gallstones, but not from 
adenomyomatosis subtype. Ultimately, this study shows the 
moderate diagnostic accuracy of the current size based sur-
gical threshold for cholecystectomy in gallbladder polyps. 
Even though 1 cm is the most optimal size threshold for dif-
ferentiating neoplastic and non-neoplastic polyps, it would 
indicate incorrect treatment for nearly a third of the patients 
with gallbladder polyps.
The relatively low prevalence of gallbladder polyps on 
cholecystectomy established in this study is in line with 
international studies [4–6]. Almost half of the polyps found 
on histopathological examination after cholecystectomy 
were non-neoplastic. Although common consensus is that 
only symptomatic or potentially malignant polyps need sur-
gery [16, 17], it remains difficult to properly differentiate 
between neoplastic and non-neoplastic polyps during the 
pre-operative phase. This study sought to identify clinico-
pathological characteristics associated with neoplastic nature 
of gallbladder polyps, in order to improve decision making 
in the pre-operative setting.
In concordance with previous studies [27–29], we con-
firm that large polyp size, presentation as a single polyp, 
presentation as wall thickening, and presence of gallstones, 
were all generally more frequent in neoplastic polyps than 
non-neoplastic polyps. Neoplastic polyps also significantly 
more often exceeded the 1 cm threshold. Superficially, these 
results are in support of international guidelines, which 
advocate cholecystectomy for polyps ≥ 1 cm [16–18, 30]. 
Recently, the accuracy of this surgical threshold as indica-
tor for surgery has been doubted [31, 32]. Even though the 
clincopathological differences in our study are statistical 
significant, we underline that neither size nor simple clin-
icopathological characteristics are sufficient to truly indicate 
neoplastic polyps for cholecystectomy.
The ROC-curve in our study confirms that 1 cm is the 
most optimal size threshold for differentiating neoplastic 
and non-neoplastic polyps, and thus for patient selection 
for cholecystectomy. However, based on the 1 cm threshold 
alone, still 32% of patients with neoplastic polyps (18% of 
gallbladder cancers and 53% of precursor lesions) would 
be withheld from surgery. Additionally, almost 900 unnec-
essary cholecystectomies for non-neoplastic polyps would 
be performed in the United States every year. A treatment 
threshold with a misclassification rate of nearly one in 
three patients is precarious to use in daily clinical practice. 
Additional patient characteristics, such as risk factors for 
malignancy (e.g., age, PSC, Indian ethnicity) or biliary 
symptoms [16, 17] that are evaluated at a second stage, may 
indicate some of the patients with neoplastic polyps < 1 cm 
for surgery. However, as long as the primary selection in all 
guidelines is polyp size [16–18, 30], mainly asymptomatic 
patients with non-neoplastic polyps ≥ 1 cm continue to be 
unnecessarily operated.
Increase or decrease of the surgical threshold alone 
will not improve patient selection for cholecystectomy. A 
size threshold of > 15 mm would exclude nearly all non-
neoplastic polyps for cholecystectomy, but up to 60% of 
neoplastic polyps would be missed. A lower cut-off of for 
example 6 mm, as suggested by Zielinski et al. [24], would 
only increase sensitivity of the surgical threshold to 78%, 
but would drop specificity to 52%. Combination of polyp 
size with other polyp characteristics assessed in this study, 
could only improve patient selection for cholecystectomy in 
specific scenarios. Five out of 16 possible clinicopathologi-
cal combinations had an 80% or higher prediction of polyp 
type. Other scenarios were as good as the 1 cm threshold 
alone, or even dropped to a 50–50 change of neoplastic or 
non-neoplastic polyp type.
Pathological and radiological characteristics are equally 
important in the differentiation of gallbladder polyps. 
Although pre-operative patient selection is based on radio-
logical imaging, it visualizes a (clinico)pathological feature 
of the polyp. If the pathological substrate that is being visu-
alized is not distinctive, the subsequent radiological image 
will not be either. The first step towards optimized patient 
selection for cholecystectomy is identification of neoplastic 
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and non-neoplastic histopathological subtypes. This study 
showed that adenomyomatosis, accounting for over one-
third of non-neoplastic polyps, has more clinicopathologi-
cal similarities with neoplastic polyps, than with other non-
neoplastic subtypes. Therefore, general polyp classification 
as “neoplastic” or “nonneoplastic” is not useful to aid in 
clinical decision making. A recent study suggested clas-
sification of polyps into three categories: “cholesterol”, 
“benign non-cholesterol” and “malignant polyps”, placing 
all non-neoplastic polyps other than cholesterol polyps in 
the same category as adenomas [31]. We strongly suggest 
differentiating more distinct subgroups, since adenomas and 
the non-neoplastic subtypes require contrary treatment. Pre-
vious studies suggested that detailed polyp features, includ-
ing polyp shape, surface, and radiological internal echogenic 
patterns should be able to differentiate between cholesterol 
polyps, inflammatory polyps, adenomyomatosis, adenomas, 
and malignant polyps [33–35]. Diagnostic accuracy of this 
dedicated (endoscopic) ultrasound imaging and the value of 
additional modalities, such as MRI, should be (re)assessed.
The strengths of this study are the large nationwide study 
population and full coverage of all pathology reports on 
gallbladder polyps in a 10-year period in the Netherlands. 
PALGA contains pathology reports of all Dutch pathology 
labs, both academic and non-academic. Pathology reports 
can be provided until the end of the year following the year 
the histopathology analysis was conducted. At time of data 
collection, PALGA database was fully updated up to and 
including 2013. Therefore, the presented data fully covered 
all primary cholecystectomies performed for gallbladder 
polyps in a 10-year period in the Netherlands.
Limitations of this study include the incomplete informa-
tion on clinicopathological characteristics from the pathol-
ogy reports and lack of clinical and radiological character-
istics of the included patients. A specified decision tree for 
distinct neoplastic and non-neoplastic subtype could not be 
provided. PALGA only collects histopathological data, with-
out indicating whether these cholecystectomies were per-
formed because of the gallbladder polyps, or that the polyps 
were incidental findings. This may have caused the inclusion 
of more small polyps, that were below the threshold of pre-
operative clinical evaluation. Additionally, we included focal 
wall thickenings > 5 mm as polyps under the hypothesis that 
some histological subtypes (malignancies, adenomyomatosis 
and inflammatory polyps) have the tendency to present as 
focal wall thickening or sessile lesions, rather than protrud-
ing polyp [33, 34, 36]. We chose the cut-off of 5 mm for 
focal wall thickening, as gallbladder walls up to 5 mm can 
be normal (e.g., due to contraction of the gallbladder) [37]. 
Focal gallbladder wall thickenings > 5 mm will be classified 
as aberrant on US and are subsequently relevant to the clini-
cians. However, our cohort may have been biased towards a 
relative higher percentage of these specific polyp types and 
smaller polyps.
In conclusion, this large nationwide cohort study estab-
lishes that ~ 1% of cholecystectomies contain a polyp and 
that 56% of these polyps are neoplastic. Polyp size, number 
of polyps, presentation as wall thickening and presence of 
gallstones differ between neoplastic and non-neoplastic pol-
yps, but cannot properly identify neoplastic polyps. Even 
though polyp size of 1 cm is the best available size based 
surgical threshold, it is insufficient to indicate cholecystec-
tomy for gallbladder polyps, due to its moderate diagnostic 
accuracy.
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